Principles of bronchodilator therapy
Bronchodilators play a key role in relieving symptoms associated with airway narrowing. The main indication for their prescription is the presence of clinical signs of bronchial obstruction. In modern clinical practice, beta2-agonists are recognized as the drugs of choice for relieving bronchospasm. A typical and most frequently used representative of this group is Salbutamol (salbutamol).
A critical aspect of successful therapy is choosing the correct route of administration. The inhalation method is considered the priority. The use of nebulizers allows the active substance to be delivered directly into the airways. This ensures a rapid therapeutic effect and minimizes systemic impact on the patient's body.
Combined use with mucolytics
When bronchial obstruction develops, monotherapy is often insufficient. In such clinical situations, bronchodilators are prescribed in strict combination with mucolytic agents. Mucolytics (such as Acetylcysteinum, Ambroxol, Dornase alfa) are necessary to thin thick secretions and facilitate their clearance.
- Hypertonic solutions: In the presence of very thick and viscous secretions, hypertonic saline solutions are indicated. Due to their pronounced osmotic effect, they help thin mucus and significantly improve mucociliary clearance.
- Features in COPD: It is worth noting an important nuance regarding chronic obstructive pulmonary disease. In this condition, the efficacy of most mucolytic agents is considered unclear. The only exception whose efficacy has been confirmed is acetylcysteine.
Emergency care for stenosing laryngotracheitis
Particular attention should be paid to the tactics of using bronchodilators in the complicated course of stenosing laryngotracheitis (croup). If bronchial obstruction syndrome joins the classic picture of croup (indicating involvement of the lower respiratory tract in the pathological process), the treatment regimen must be urgently expanded.
In this situation, immediate nebulizer inhalation is indicated:
- Bronchodilators: short-acting beta2-agonists (Salbutamol) or combination drugs (Ipratropium bromide + Fenoterol) are used.
- Inhaled corticosteroids (ICS): budesonide suspension (Budesonide) is the drug of choice.
Additionally, if the patient has a burdened allergic history (atopy) and the course of croup is assessed as mild to moderate (grade I–II laryngeal stenosis), the inclusion of 2nd generation H1-antihistamines in the regimen is pathogenetically justified.
Post-stenotic period therapy
After acute laryngeal stenosis is successfully resolved, the post-stenotic period (convalescence period) begins. If the patient continues to cough, the management tactics change dramatically: the foreground shifts from relieving spasms to improving mucociliary clearance—thinning and adequate evacuation of sputum.
To achieve this goal, specialized mucolytics are prescribed, such as Acetylcysteinum (acetylcysteine), Carbocisteine (carbocisteine), or Ambroxol (ambroxol). The route of administration can be either oral or inhalation.
In addition, complex drugs can be used during the resolution phase of croup. The physician may prescribe combination drugs that have both expectorant and bronchodilator effects simultaneously. A classic example of such a combination is a preparation containing Salbutamol, Bromhexine, and Guaifenesin (salbutamol + bromhexine + guaifenesin).
The obstruction linkage: Bronchodilator expands, Mucolytic clears. During a spasm, we always start with a beta2-agonist (salbutamol) and then add agents to thin the sputum.
Class and exam questions
Which route of administration for bronchodilators and mucolytics is considered a priority?
The inhalation route is optimal. It ensures the delivery of the active substance directly into the airways, which accelerates the onset of the effect.
What is prescribed if bronchial obstruction joins the clinical picture of croup?
In this case, therapy is expanded. Short-acting beta2-agonists (e.g., salbutamol) or combination drugs, as well as inhaled corticosteroids (budesonide suspension), are administered via a nebulizer.
How do management tactics change in the post-stenotic period of croup?
When acute stenosis is relieved, improving mucociliary clearance becomes the primary goal. Mucolytics or combination drugs containing expectorant and bronchodilator components are prescribed for sputum evacuation.
Is the prescription of mucolytics justified in COPD?
According to available data, the efficacy of most mucolytics in chronic obstructive pulmonary disease is considered unclear. The only exception is acetylcysteine.
What else to study on this topic
- Mechanism of action of short-acting beta2-agonists
- Pharmacological properties of inhaled corticosteroids
- Osmotic effect of hypertonic saline solutions
- Classification of mucolytics and improvement of mucociliary clearance
- The role of 2nd generation H1-antihistamines in atopy
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Bronchodilators" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.